Skip to search.
 TSX Up 0.25% TSX Ventures Down 0.06%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
399.70 Down 3.27(0.81%) 3:55PM EDT - Nasdaq Real Time Price
Prev Close:402.97
Open:405.15
Bid:400.51 x 100
Ask:400.80 x 100
1y Target Est:466.64
Beta:1.45112
Earnings Date:Nov 2 - Nov 7 (Est.)
Day's Range:396.59 - 405.99
52wk Range:329.09 - 592.59
Volume:498,941
Avg Vol (3m):827,048
Market Cap:42.90B
P/E (ttm):62.36
EPS (ttm):6.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
REGNDown 0.81%42.90B
AMGNDown 0.23%128.40B

Key Statistics

Forward P/E (1 yr):27.78
P/S (ttm):9.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :10.93
Quarterly EPS Est (Sep-16) :2.73
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback